Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Registrati

Home
Investire
Azioni
U.S.A.
NASDAQ
Virax Biolabs Group Ltd (VRAX)
Virax Biolabs Group Ltd (VRAX) Notizie

VRAX

Virax Biolabs (VRAX)

Virax Biolabs Group Ltd

Da:

Notizie Regolamentate

Cerca Testo:

Ordina per:

Notizie Non Regolamentate

Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VRAX

Data	Ora	Fonte	Titolo	Simbolo	Compagnia
18/03/2025	13:10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
18/03/2025	12:30	PR Newswire (US)	Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes	NASDAQ:VRAX	Virax Biolabs Group Ltd
13/03/2025	12:30	PR Newswire (US)	Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting	NASDAQ:VRAX	Virax Biolabs Group Ltd
05/03/2025	13:30	PR Newswire (US)	Virax Biolabs to Present at 19th World Immune Regulation Meeting	NASDAQ:VRAX	Virax Biolabs Group Ltd
25/02/2025	13:00	PR Newswire (US)	Virax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine Efficacy	NASDAQ:VRAX	Virax Biolabs Group Ltd
30/01/2025	22:45	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:VRAX	Virax Biolabs Group Ltd
17/12/2024	13:30	PR Newswire (US)	Virax Biolabs' CEO James Foster Issues Letter to Shareholders	NASDAQ:VRAX	Virax Biolabs Group Ltd
10/12/2024	13:30	PR Newswire (US)	Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland	NASDAQ:VRAX	Virax Biolabs Group Ltd
23/10/2024	13:30	PR Newswire (US)	Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland	NASDAQ:VRAX	Virax Biolabs Group Ltd
30/09/2024	15:13	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VRAX	Virax Biolabs Group Ltd
16/09/2024	14:30	PR Newswire (US)	Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.	NASDAQ:VRAX	Virax Biolabs Group Ltd
09/09/2024	14:00	PR Newswire (US)	Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference	NASDAQ:VRAX	Virax Biolabs Group Ltd
29/08/2024	15:03	PR Newswire (US)	Virax Biolabs to Participate at 7th European Congress of Immunology	NASDAQ:VRAX	Virax Biolabs Group Ltd
28/08/2024	13:30	PR Newswire (US)	Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East	NASDAQ:VRAX	Virax Biolabs Group Ltd
23/08/2024	22:09	PR Newswire (US)	Virax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares	NASDAQ:VRAX	Virax Biolabs Group Ltd
22/08/2024	03:30	PR Newswire (US)	Virax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary Shares	NASDAQ:VRAX	Virax Biolabs Group Ltd
20/08/2024	22:24	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:VRAX	Virax Biolabs Group Ltd
01/08/2024	13:48	Edgar (US Regulatory)	Form NT 20-F - Notification of inability to timely file Form 20-F	NASDAQ:VRAX	Virax Biolabs Group Ltd
25/04/2024	14:00	PR Newswire (US)	Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024	NASDAQ:VRAX	Virax Biolabs Group Ltd
16/04/2024	13:30	PR Newswire (US)	Virax Biolabs to Participate at ESCMID Global 2024	NASDAQ:VRAX	Virax Biolabs Group Ltd
15/03/2024	21:30	PR Newswire (US)	Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency	NASDAQ:VRAX	Virax Biolabs Group Ltd
21/12/2023	13:30	PR Newswire (US)	Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients	NASDAQ:VRAX	Virax Biolabs Group Ltd
20/12/2023	22:12	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VRAX	Virax Biolabs Group Ltd
18/12/2023	06:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VRAX	Virax Biolabs Group Ltd
14/12/2023	13:30	PR Newswire (US)	Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation	NASDAQ:VRAX	Virax Biolabs Group Ltd
05/12/2023	22:06	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:VRAX	Virax Biolabs Group Ltd
17/10/2023	22:05	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:VRAX	Virax Biolabs Group Ltd
12/09/2023	13:30	PR Newswire (US)	Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar	NASDAQ:VRAX	Virax Biolabs Group Ltd
01/09/2023	13:30	PR Newswire (US)	Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum	NASDAQ:VRAX	Virax Biolabs Group Ltd
03/08/2023	13:30	PR Newswire (US)	Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid	NASDAQ:VRAX	Virax Biolabs Group Ltd

Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VRAX

Super Group SGHC

EDU Coin [Open Campus]

AMUNDI WELM INAV

BTG PACTUAL PNA

Compass Gas E Energia PNA

Kimberly Cl DRN

Aptus Defined Risk ETF

Delayed Upgrade Clock

Assistenza: help@advfn.com

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni